During this recorded webinar our presenters discuss the latest research on the impact of therapeutic inertia on diabetes care. They then take a look inside ADA’s multi-year Overcoming Therapeutic Inertia (OTI) initiative to help you effectively bust through inertia in clinical practice. Ushering in a paradigm shift in the care of type 2 diabetes, the OTI initiative aims to advance the latest thought-leadership, resources, and tools in overcoming therapeutic inertia to help primary care clinicians more effectively partner with their patients with diabetes to help them live longer healthier lives. This webinar culminates with a case study reviewing what might be contributing to therapeutic inertia in your practice with explicit recommendations addressing it quickly.

Instructors: Stephen Brunton, MD; Kamlesh Khunti, MD, PhD

Learning Objectives:

• Describe a working definition of therapeutic inertia

• Discuss the benefits of the legacy effect and metabolic memory and how they improve patient outcomes

• Describe the evidence for failure to advance or de-intensify treatment and the impact on clinical outcomes

• Identify contributors to therapeutic Inertia in clinical practice

About Instructors:

Stephen Brunton, MD is Executive Vice President for Education for the Primary Care Education Consortium. He works in a group practice in suburban Los Angeles, California, and holds the faculty rank of Adjunct Clinical Professor in the Department of Pharmacy Practice at Roseman University of Health Sciences in Salt Lake City, Utah. He currently also serves as the Editor-in-Chief for Clinical Diabetes, a journal of the American Diabetes Association, and is the Executive Director of the Primary Care Metabolic Group.

Kamlesh Khunti, MD, PhD is Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, UK. He is Co-Director of the Leicester Diabetes Centre and leads a research group that is currently working on the early identification of, and interventions with, people who have cardiometabolic disease or are at increased risk of developing cardiometabolic diseases. Dr. Khunti is a leading researcher on the impact of therapeutic inertia on diabetes care.